General Information of This Metabolic Reaction (MR) (ID:
MR002045) |
Formula |
|
Reactant |
Pioglitazone metabolite M-II |
Product |
Pioglitazone metabolite M-XI |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 2C8 (CYP2C8)
|
DME Info
|
Metabolic Type
|
Oxidation
-
Oxidation
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Produce The Reactant of This MR
|
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors. Basic Clin Pharmacol Toxicol. 2006 Jul;99(1):44-51.
|
2 |
Simultaneous quantitation of pioglitazone and its metabolites in human serum by liquid chromatography and solid phase extraction J Pharm Biomed Anal. 1996 Feb;14(4):465-73. doi: 10.1016/0731-7085(95)01665-1.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.